“…Despite the claims for the two test preparations of an excellent therapeutic index with minimal side-effect potential over a substantial range of doses, the published reports are not unanimous. Certain authors report significant HPA axis suppression at relatively low doses (9,10), others only at higher dosage levels (3,4,6,17).…”